Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma company

    Tag: pharma company

    You Searched For "pharma company"
    Dr Reddys gets EIR from USFDA for manufacturing plants at Duvvada

    Dr Reddys gets EIR from USFDA for manufacturing plants at Duvvada

    Medical Dialogues Bureau13 Sept 2019 11:59 AM IST
    The company has received EIR from the United States Food and Drug Administration (USFDA) for the inspection conducted at the formulations...
    First AI-powered X-ray System: GE Healthcare bags USFDA approval

    First AI-powered X-ray System: GE Healthcare bags USFDA approval

    Medical Dialogues Bureau13 Sept 2019 9:30 AM IST
    Built-in collaboration with UC San Francisco (UCSF), using GE Healthcare's Edison platform, the AI algorithms help to reduce the turn-around time it...
    Sanofi India sells oldest facility at Ankleshwar to Advent for Rs 262 crore

    Sanofi India sells oldest facility at Ankleshwar to Advent for Rs 262 crore

    Medical Dialogues Bureau12 Sept 2019 5:41 PM IST
    The Ankleshwar site is Sanofi India's oldest manufacturing facility where brands like Combiflam, Allegra and Amaryl are made. The production of these...
    Strides Pharma infuses Rs 15.50 crore in Fairmed for 70pc stake

    Strides Pharma infuses Rs 15.50 crore in Fairmed for 70pc stake

    Medical Dialogues Bureau12 Sept 2019 10:00 AM IST
    The company's step-down subsidiary Strides Pharma Global has acquired a majority stake in Fairmed Healthcare AG which has a portfolio of generic...
    Alkem Labs gets EIR from USFDA for St.Louis facility

    Alkem Labs gets EIR from USFDA for St.Louis facility

    Medical Dialogues Bureau12 Sept 2019 9:30 AM IST
    "In furtherance to the intimation captioned "US FDA Inspection at Alkem's manufacturing facility located at St. Louis, USA" dated 23rd August, 2019,...
    Jubilant Life appoints Novartis Syed Kazmi as President, CEO of its new biotech startup

    Jubilant Life appoints Novartis Syed Kazmi as President, CEO of its new biotech startup

    Medical Dialogues Bureau11 Sept 2019 9:25 AM IST
    Dr Syed Kazmi joins from Novartis Pharmaceuticals Corporation where he was Vice President, Global Head of Business Development & Licensing for...
    Shilpa Medicare gets 2 USFDA observations for Telangana facility

    Shilpa Medicare gets 2 USFDA observations for Telangana facility

    Medical Dialogues Bureau9 Sept 2019 11:50 AM IST
    The US Food and Drug Administration (USFDA) inspected the company's finished dosage formulation facility located at Pharmaceutical Formulations SEZ,...
    Novartis wins USFDA breakthrough tag for Capmatinib to treat lung cancer

    Novartis wins USFDA breakthrough tag for Capmatinib to treat lung cancer

    Medical Dialogues Bureau8 Sept 2019 9:25 AM IST
    Novartis is aiming to win approval for oral capmatinib as a first-line treatment for patients with metastatic MET exon14 skipping-mutated non-small...
    Bristol-Myers blockbuster Opdivo fails to meet goal of brain tumour study

    Bristol-Myers blockbuster Opdivo fails to meet goal of brain tumour study

    Medical Dialogues Bureau8 Sept 2019 9:15 AM IST
    The drug, Opdivo, when used along with the current standard of care for glioblastoma multiforme, did not prevent cancer from spreading when compared...
    Cigna new plan to cover expensive gene therapies including Novartis Zolgensma, Luxturna

    Cigna new plan to cover expensive gene therapies including Novartis Zolgensma, Luxturna

    Medical Dialogues Bureau8 Sept 2019 9:00 AM IST
    The first two gene therapies to be included in Cigna Corp's program are blindness therapy, Luxturna, and the most expensive drug in the world...
    Cipla, B J Wadia Hospital enter partnership to set up paediatric palliative care unit

    Cipla, B J Wadia Hospital enter partnership to set up paediatric palliative care unit

    Medical Dialogues Bureau7 Sept 2019 9:40 AM IST
    Cipla Foundation strongly believes that palliative care focuses on providing relief from symptoms and stress of illness at any point, yet most...
    Sumitomo Dainippon Pharma to acquire 10pc stake in Roivant Sciences for USD 3 billion

    Sumitomo Dainippon Pharma to acquire 10pc stake in Roivant Sciences for USD 3 billion

    Medical Dialogues Bureau7 Sept 2019 9:00 AM IST
    The deal, which will open up new drug lines for Sumitomo Dainippon, will also give it the option to acquire interests in an additional six businesses,...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok